e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary infections and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcomes of patients on multiple vasopressor therapy
C. Prys-Piccard, B. Williams, V. Cardenas, G. Sharma (Galveston, United States Of America)
Source:
Annual Congress 2010 - Pulmonary infections and sepsis
Session:
Pulmonary infections and sepsis
Session type:
Thematic Poster Session
Number:
4252
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Prys-Piccard, B. Williams, V. Cardenas, G. Sharma (Galveston, United States Of America). Outcomes of patients on multiple vasopressor therapy. Eur Respir J 2010; 36: Suppl. 54, 4252
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Related content which might interest you:
Outcomes of Fibrinolytic therapy for acute empyema.
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017
Year: 2017
Outcomes of patients with COVID-19 pneumonia treated with CPAP
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
Nicotine replacement therapy in ICU patients
Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases
Year: 2012
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021
CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
The effect of frequent use of hypnotics on HRQOL in patients receiving LTOT and/or long-term NIV
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Outcome of two patients with lymphangioleiomyomatosis without anti-estrogen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 96s
Year: 2006
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Outcome of failed empirical antibiotic therapy on the mortality of elderly patients with hospitalized pneumonia: A propensity score-based analysis
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Outcomes in patients requiring CPAP for COVID-19 infection in non-ITU settings
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
Assessment and therapy for COPD patients in real-life primary care
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Outcomes of pulmonary rehabilitation according maintenance treatment in real life COPD patients
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012
Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept